Mereo BioPharma Group plc (NASDAQ:MREO) People
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Annalisa Jenkins Other companies: Skye Bioscience, Inc. (Director · Since at least Feb 29, 2024); COMPASS Pathways Plc (Director · Since at least Jan 1, 2022); Serina Therapeutics, Inc. (Director · Nov 27, 2018 – Jun 21, 2021 · Past); Tectonic Therapeutic, Inc. (Director · Jun 20, 2018 – Jun 6, 2023 · Past); Dimension Therapeutics (President and CEO, Director · Oct 21, 2015 – Nov 7, 2017 · Past); Ardelyx, Inc. (Director · Apr 20, 2015 – Jun 13, 2019 · Past) | Director · Since at least Jan 1, 2024 |
| Jeremy Bender Other companies: Bicara Therapeutics Inc. (Director · Since at least Jul 28, 2026); Aura Biosciences, Inc. (Director · Since at least Jul 7, 2026); Day One Biopharmaceuticals Inc (CHIEF EXECUTIVE OFFICER, Director · Since at least May 26, 2021); Fusion Pharmaceuticals Inc (Director · Oct 16, 2023 – Jun 4, 2024 · Past) | Non-Executive Director · Since at least Jan 1, 2024 |
| Michael Wyzga Other companies: X4 Pharmaceuticals, Inc. (Director · Since at least Jun 9, 2025); Tvardi Therapeutics, Inc. (Board Member · Since at least Apr 15, 2025) | Director · Since at least Feb 26, 2026 |
| Justin H. Roberts Other companies: TherapeuticsMD, Inc. (Board Member · Since at least Aug 23, 2022) | Non-Executive Director · Since at least Jan 1, 2024 |
| Pierre Jacquet Other companies: EXACT Sciences Corporation (Director · Jun 9, 2022 – Jun 8, 2023 · Past) | Non-Executive Director · Since at least Jan 1, 2024 |
| Alexandra Hughes-Wilson | See Remarks · Since at least Jan 1, 2024 |
| Anders Ekblom | Non-Executive Director · Since at least Nov 5, 2026 |
| Bal Lally | Vice President, Head of HR · Since at least Nov 4, 2026 |
| Bharti Navsariwala | Vice President, Head of Regulatory Affairs · Since at least Nov 4, 2026 |
| Bo Kara | Senior Vice President, Head of Pharmaceutical Development · Since at least Nov 4, 2026 |
| Charles Sermon | General Counsel and Business Development · Since at least Jan 1, 2024 |
| Christine Fox | Chief Financial Officer · Since at least Jan 1, 2024 |
| Daniel Shames | Non-Executive Director · Since at least Nov 5, 2026 |
| Deepa Pakianathan | Non-Executive Director · Since at least Nov 5, 2026 |
| Denise Scots-Knight | Chief Executive Officer · Since at least Mar 19, 2026 |
| Jackie Parkin | Senior Vice President, Therapeutic Head · Since at least Nov 4, 2026 |
| John Lewicki | Chief Scientific Officer · Since at least Nov 4, 2026 |
| Marc Yoskowitz | Non-Executive Director · Since at least Nov 5, 2026 |
| Ogün Sazova | Vice President, Clinical Development and Medical Affairs · Since at least Nov 4, 2026 |
| Wills Hughes-Wilson | Chief Patient Access and Commercial Planning · Since at least Nov 4, 2026 |